<p>A549, Hela, HGC-27, or MDA-MB-453 cells were incubated with the indicated concentrations of LJK-11 for 48 hours. The effect of LJK-11 on cell growth and death was evaluated by MTT assay. The cell viability is expressed as a percentage of the compound-treated viable cells divided by the viable cells of the untreated control. The data are the means of triplicates ±SD.</p
<p>RAW 264.7 cells were treated with various concentrations of each peptide or vehicle for 48 h and ...
<p>KMS34 (1.2×10<sup>7</sup> cells) were injected intraperitoneally into lcr/scid mice and plasmacyt...
<p>Human fibrosarcoma HT1080 cells <b>(A)</b> and murine hepatocytes <b>(B)</b> were treated with th...
<p>A. Flow cytometry analysis of LJK-11-treated A549 tumor cells. A549 cells were incubated with dif...
<p>(A,B) MM cell lines were challenged with either TPCA-1 (20 µM) or Bay 11-7082 (30 µM) for 4 h (A)...
<p><b>A</b>. Flow cytometry analysis of the effects of LJK-11 (10 µM), colchicines (20 nM), or the c...
<p>KMS34 cells (1×10<sup>4</sup> cells/well) in 96-well plate were incubated with 0–50 µM of indicat...
<p>Hela cells were incubated with 50 µM LJK-11 or 20 nM colchicine for 20 hours (A) and then the com...
<p>(A) Structure of Lck inhibitor A-770041. (B) Percent of viable cells of LCL-WT, LCL-FLAG-LMP1 and...
<p>The viability curves of B cells and PBMCs after four days of incubation with different concentrat...
<p>A549 cells were incubated on glass coverslips with different reagents for 16 hours, and then fixe...
<p>ARPE19 cells were treated with 6-15 µM 7KCh for 24 hr and the cell viability was measured by dete...
<p>(A) The chemical structures of TC11, thalidomide, and lenalidomide. (B) The dose-dependent inhibi...
<p>Cells were treated with the indicated concentration of compounds <b>4</b>, <b>10</b>, <b>13</b> a...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>RAW 264.7 cells were treated with various concentrations of each peptide or vehicle for 48 h and ...
<p>KMS34 (1.2×10<sup>7</sup> cells) were injected intraperitoneally into lcr/scid mice and plasmacyt...
<p>Human fibrosarcoma HT1080 cells <b>(A)</b> and murine hepatocytes <b>(B)</b> were treated with th...
<p>A. Flow cytometry analysis of LJK-11-treated A549 tumor cells. A549 cells were incubated with dif...
<p>(A,B) MM cell lines were challenged with either TPCA-1 (20 µM) or Bay 11-7082 (30 µM) for 4 h (A)...
<p><b>A</b>. Flow cytometry analysis of the effects of LJK-11 (10 µM), colchicines (20 nM), or the c...
<p>KMS34 cells (1×10<sup>4</sup> cells/well) in 96-well plate were incubated with 0–50 µM of indicat...
<p>Hela cells were incubated with 50 µM LJK-11 or 20 nM colchicine for 20 hours (A) and then the com...
<p>(A) Structure of Lck inhibitor A-770041. (B) Percent of viable cells of LCL-WT, LCL-FLAG-LMP1 and...
<p>The viability curves of B cells and PBMCs after four days of incubation with different concentrat...
<p>A549 cells were incubated on glass coverslips with different reagents for 16 hours, and then fixe...
<p>ARPE19 cells were treated with 6-15 µM 7KCh for 24 hr and the cell viability was measured by dete...
<p>(A) The chemical structures of TC11, thalidomide, and lenalidomide. (B) The dose-dependent inhibi...
<p>Cells were treated with the indicated concentration of compounds <b>4</b>, <b>10</b>, <b>13</b> a...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>RAW 264.7 cells were treated with various concentrations of each peptide or vehicle for 48 h and ...
<p>KMS34 (1.2×10<sup>7</sup> cells) were injected intraperitoneally into lcr/scid mice and plasmacyt...
<p>Human fibrosarcoma HT1080 cells <b>(A)</b> and murine hepatocytes <b>(B)</b> were treated with th...